Due to these beneficial effects of GLP-1R activation on metabolism, several drugs have been developed that act on the GLP-1 receptors, including the GLP-1RAs liraglutide, dulaglutide and exendin-4, used in the treatment of T2DM and obesity (101). Here, GLP1R is linked to type 2 diabetes mellitus.